Implicit and Explicit Assessment of Suicide Risk

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

Eligibility criteria

Qualifiers

Person presenting to emergencies for psychiatric reasons

Adult person

Free and informed consent signed

Person speaking and writing French fluently

Disqualifiers

Neurological disorders or major cognitive deterioration: presence of confusion

Acute psychotic decompensation

Troubled acute behavior

Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment

Trial design

Treatments tested in this trial

  • Implicit Attitude Test

Treatment groups

108 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Centre Hospitalier Pinel d'Amiens

Collaborator